Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

43.44
Delayed Data
As of Jul 31
 -0.15 / -0.34%
Today’s Change
41.19
Today|||52-Week Range
49.24
+1.64%
Year-to-Date

Today’s Trading

Previous close43.59
Today’s open43.68
Day’s range43.37 - 43.71
Volume4,247,055
Average volume (3 months)4,122,208
Market cap$105.7B
Dividend yield5.73%
Data as of 4:03pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-46.46%
Earnings growth (this year)-20.70%
Earnings growth (next 5 years)+5.20%
Revenue growth (last year)-8.75%
P/E ratio10.4
Price/Sales2.74
Price/Book15.89

Competitors

 Today’s
change
Today’s
% change
CELGCelgene-0.63-0.48%
BMYBristol-Myers Squibb+1.18+1.83%
ABBVAbbVie-0.15-0.21%
LLYEli Lilly and Co-0.03-0.04%
Data as of 4:04pm ET, 07/31/2015

Financials

Next reporting dateOctober 28, 2015
EPS forecast (this quarter)$0.64
Annual revenue (last year)$37.9B
Annual profit (last year)$4.5B
Net profit margin11.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts